RAP 3.64% 5.7¢ resapp health limited

Motley Fool Likes RAP

  1. 91 Posts.
    lightbulb Created with Sketch. 31

    Resapp Health Ltd (ASX: RAP) shares are up 6.3% to 34 cents this morning after it announced a partnership with Massachusetts General Hospital to conduct a clinical study aimed at gathering evidence for a potential submission to the US FDA. ResApp develops smartphone medical applications for the diagnosis and management of respiratory diseases and has an evangelical-like following of retail shareholders hoping the company can deliver on its potential. The market cap is nearly $200 million – large for a company with no revenues and a net operating cash flow loss of $612,000 for the quarter ending 31 March 2016, although it reportedly has some exciting potential.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
(20min delay)
Mkt cap ! $43.21M
Open High Low Value Volume
5.4¢ 5.9¢ 5.4¢ $156.2K 2.758M

Buyers (Bids)

No. Vol. Price($)
2 107156 5.6¢

Sellers (Offers)

Price($) Vol. No.
5.7¢ 27316 2
View Market Depth
Last trade - 16.10pm 01/03/2021 (20 minute delay) ?
0.002 ( 3.64 %)
Open High Low Volume
5.4¢ 5.7¢ 5.4¢ 48014
Last updated 13.32pm 01/03/2021 (live) ?
RAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.